Do endothelial progenitor cells modify our strategy to treat risk factors?
Prif Awduron: | Tousoulis, D, Andreou, I, Antoniades, C, Siasos, G, Stougiannos, P, Trikas, A, Stefanadis, C |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2011
|
Eitemau Tebyg
-
Do endothelial progenitor cells modify our strategy to treat risk factors?
gan: Tousoulis, D, et al.
Cyhoeddwyd: (2010) -
Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
gan: Andreou, I, et al.
Cyhoeddwyd: (2006) -
Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
gan: Tousoulis, D, et al.
Cyhoeddwyd: (2008) -
Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.
gan: Bakogiannis, C, et al.
Cyhoeddwyd: (2012) -
The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development.
gan: Briasoulis, A, et al.
Cyhoeddwyd: (2011)